To read more on this topic click here.
MJFF announces $10 million competition for Parkinson’s
Author: Simge Eva DoganPublished: 26 September 2019
Prep: Cook: Serves:
The Michael J Fox Foundation has launched the ‘Ken Griffin Alpha-synuclein Imaging Competition’ – a US $10 million programme aiming to develop a game-changing tool for Parkinson’s research.
As part of the competition, participating teams will compete in a scientific race to build a device that is able to identify alpha-synuclein – a protein closely associated with Parkinson’s. Although almost everyone diagnosed with Parkinson’s has clumps of alpha-synuclein in the brain, these are currently only visible when analysing tissue during autopsies.
The competition is named after Ken Griffin, CEO of US investment firm Citadel who has given US $7.5 million funding to the programme.
Griffin – whose father has Parkinson’s – said: “If we have the imaging capability to observe the pathology that arises from protein-misfolding in real time, and understand how drugs are impacting people in real time, that would be a major advance.”
Share this story
Why you need more vitamin B3 in your diet
Discover the added value of vitamin B3 for Parkinson’s patientsREAD MORE
Young-onset Parkinson’s disease: the challenges and treatment options
Register for this free, hour-long webinarREAD MORE
Creative and living with Parkinson’s? Showcase your work in the Mervyn Peake Awards
Art competition: get your entries in for a chance to exhibit workREAD MORE